Loading data for BFRI — first visit, this takes a few seconds.
Biofrontera Inc. (BFRI)
NasdaqCM: BFRI
· Real-Time Price · USD
1.59
+0.10 (6.71%)
At close: Aug 28, 2026, 3:59 PM
1.58
-0.62%
After-hours: 7:59 PM
The price, the headline numbers and the latest news, in one place.
Biofrontera Inc. (BFRI) Stock Price, Analysis & Data
6.71% (1D)
| Bid | 1.14 |
| Market Cap | 23.62M |
| Revenue (ttm) | 46.17M |
| Net Income (ttm) | -6.37M |
| 0.80 | |
| -0.43 | |
| n/a | |
| 3.7 | |
| P/B (ttm) | 3.79 |
| P/S (ttm) | 0.51 |
| Earnings Date | Nov 11, 2026 |
| Ask | 1.94 |
| Volume | 804,156 |
| Avg. Volume (20D) | 401,183 |
| Open | 1.53 |
| Previous Close | 1.49 |
| Day's Range | 1.51 - 1.61 |
| 52-Week Range | 0.56 - 1.61 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BFRI
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts....
Sector Healthcare
IPO Date Oct 29, 2021
Employees 84
Stock Exchange NasdaqCM
Ticker Symbol BFRI
Website https://www.biofrontera-us.com
Financial Performance
In 2025, Biofrontera's revenue was 41.7M, an increase of 11.75% compared to the previous year's 37.32M. Earnings were -10.54M, a decrease of -40.67%.
Financial StatementsEarnings Surprise
Biofrontera has released their quarterly earnings on Aug 13, 2026:
- Revenue of $10.08M misses estimates by $0, with 17.42% YoY growth.
- EPS of -0.05 misses estimates by -0.01, with 91.23% YoY growth.
Biofrontera Inc. is scheduled to release its earnings on Nov 11, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2